| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zivo Bioscience, Inc. (ZIVO) has 4 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. ZIVO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 577.9K | $2.13M | - | |
| 10% | 517.5K | $1.91M | - | |
| 10% | 452.9K | $1.67M | - | |
| Dir | 1.2K | $4.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 12, 2017 | Maggiore Christopher D. | Director, 10% Owner | Buy | 84,000 | $0.07 | $5,778.00 | +0.2% | |
| Apr 27, 2017 | Maggiore Christopher D. | Director, 10% Owner | Buy | 114,000 | $0.07 | $7,467.10 | +0.3% | |
| Apr 29, 2016 | Hep Investments LLC | 10% Owner | Buy | 107,064 | $0.08 | $8,565.12 | +8.7% | |
| Apr 28, 2015 | Hep Investments LLC | 10% Owner | Buy | 299,400 | $0.13 | $39,850.14 | +24.1% | |
| Apr 6, 2015 | Maggiore Christopher D. | Director, 10% Owner | Buy | 50,000 | $0.08 | $4,245.00 | +0.4% | |
| Jan 6, 2015 | Maggiore Christopher D. | Director, 10% Owner | Buy | 39,069 | $0.09 | $3,405.91 | +0.1% |